Late Night Market Recap

 night.owl
 
  night.owl
 
Follow  Message
 
 
 
Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.
 

•  17 Nov 2025
 

•   ARMK  
   
  -0.61%
•   AS  
   
  +7.61%
•   CAN  
   
  +5.88%
•   CSIQ  
   
  -3.20%
•   DELL  
   
  -0.90%

$CAN traded lower on heavy volume ahead of its earnings report scheduled for Tuesday. With nearly 34.8M shares moved, traders clearly positioned early as expectations circled around the ability to steady its fundamentals. The pre-earnings weakness set up a potentially sharp reaction once numbers drop.

$GOOG Berkshire Hathaway stake continued to ripple through the market. From analyst upgrades to fresh AI optimism, Alphabet momentum fed into the broader narrative that big-cap tech can still surprise even after a banner year. Every headline seemed to build on the last, pushing the stock toward fresh highs as traders tried to keep up.

$HIMS drifted lower despite news of a $250M share buyback authorization. Volume surged past 26M as the market weighed competitive pressure against management confident tone. While buybacks usually excite the tape, traders were more focused on near-term resistance levels and how HIMS plans to defend market share heading into next year.

$DELL took one of the hardest hits of the session on nearly 14.4M shares after a sharp double downgrade and renewed margin worries triggered a fast retreat. Hardware names broadly weakened, but Dell bore the brunt as rising memory costs and cautious analyst language pushed sentiment sharply negative. By the closing bell, traders were already debating whether the selloff was overdone or just beginning.

$CSIQ faced another wave of pressure. With 10.4M shares traded, the stock reacted strongly to a new analyst note calling for downside and to uncertainty around the latest European expansion. Even a fresh storage contract announcement couldn’t shift the tone as sellers stayed in control.

$ARMK fell after reporting revenue growth that failed to meet lofty expectations. More than 9.1M shares changed hands as traders digested results that were neither disastrous nor inspiring. The long-term revenue targets remained intact, but the quarter didn’t give bulls the spark they hoped for.

$AS inched higher on strong volume ahead of earnings scheduled for Tuesday. Investors seemed cautiously optimistic as they considered how demand trends in sports equipment and lifestyle categories may impact profitability. The setup going into the print looked measured but optimistic.

$JNJ gained 1.9% as the market welcomed positive clinical data and news of multiple strategic moves including its acquisition of Halda Therapeutics. The stock traded more than 6.9M shares as traders evaluated the strengthening pipeline and the steady stream of catalysts. Late in the session, sentiment tilted firmly constructive as the story broadened beyond a single headline.

View All Headlines